Latest News
|
12 September 2012
1 Likes 
Federal regulators have debarred two researchers formerly employed by Kansas-based Lee Research Institute for falsifying data obtained from a clinical trial conducted on behalf of Schering-Plough, now
Read More...
Latest News
|
6 August 2012
0 Likes
Generic versions of Merck's pharmaceutical blockbuster Singulair (montelukast sodium) are now available to consumers, making it the latest product to fall off the so-called 'patent cliff,' the US Food
Read More...
Latest News
|
19 July 2012
0 Likes
The US Food and Drug Administration’s (FDA) Bad Ad Program, an effort to encourage physicians and other healthcare providers to report “suspected untruthful or misleading prescription drug promotion,”
Read More...
Latest News
|
21 June 2012
0 Likes
Merck & Co might be wishing it had just stuck with Antonio Banderas to market its allergy products. In a sharply-worded letter to the US Federal Trade Commission, a group of public advocacy groups is
Read More...
Latest News
|
8 May 2012
0 Likes
An investigation by the US House Energy and Commerce Committee that began in January 2012 continues to escalate, with members of the committee directly targeting pharmaceutical companies in an attempt
Read More...
Latest News
|
20 April 2012
0 Likes
US pharmaceutical manufacturer Merck & Co. has settled criminal charges over the company’s marketing of its painkiller drug Vioxx, reports Bloomberg.Merck will pay a $321.6 million criminal fine after
Read More...
Latest News
|
12 April 2012
0 Likes
Shortly after the US Food and Drug Administration (FDA) released new rules to curtail the “injudicious” use of antibiotics in food-producing animals, three pharmaceutical manufacturers said they were
Read More...
Latest News
|
29 February 2012
0 Likes
Merck Sharp and Dohme Corp.’s global director of regulatory affairs received a warning letter on 17 February from the US Food and Drug Administration warning Merck that it had failed to complete an
Read More...